Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Afren 2011 Pretax Profit Surges - Quick Facts

Afren plc (AFR.L) Tuesday posted a sharply higher 2011 pretax profit of $221 million, compared to the prior-year's $79 million. Per-share earnings went up to 11.5 cents from 4.8 cents, with earnings from continuing operations of 11.9 cents per share in 2011 and 4.9 cents per share a year ago.

Revenue for the period was $596.7 million, rising from 2010's $319.4 million, reflecting start of production at the Ebok field. The company's 2011 revenues estimate, as of January 23, 2012, saw revenues of around $600 million.

Click here to receive FREE breaking news email alerts for Afren plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.